EGFR and lung carcinoma: For instance propranolol, an antagonist of the GNAS coupled β2 andrenergic receptor (ADRAB2), improves prognosis in thick skin melanoma [40] and abrogates EGFR inhibitor resistance acquisition in lung cancer [41].